HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mass Retailer Recognition Of Multicultural Market Potential Urged By P&G

This article was originally published in The Rose Sheet

Executive Summary

Mass retailers must capitalize on the power of the multicultural beauty market with bilingual in-store promotions and literature, Procter & Gamble Cosmetics VP/General Manager Marc Pritchard advised.

You may also be interested in...



Clairol $50 Mil. Marketing Boost Part Of P&G Blueprint For Growth

Procter & Gamble plans to increase marketing spending on Clairol by approximately $50 mil. within its first year of acquiring the hair care business to "restore competitive marketing," President and CEO A.G. Lafley said during a May 21 analyst meeting outlining plans for the purchase.

Clairol Herbal Essences Color Launch Includes Internet Sampling

Clairol expects Herbal Essences Haircolor, fueled by a big marketing push including an Internet sampling campaign, to capture a 10% dollar share of the hair color category within 18 months of its debut, the company said during a launch event in New York City March 13. The 30-SKU collection will bow in May.

Cover Girl Outlast Marketing To Include Hispanic Focus

Procter & Gamble's launch of Cover Girl Outlast All-Day LipColor will include Spanish-language advertising directed to the growing Hispanic-American market. Ad support for the new lipstick is slated to begin in April (1"The Rose Sheet" Feb. 12, p. 4).

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel